"Am I eligible for GLP-1 therapy?" turns on a combination of BMI, comorbidities, indication, and the specific provider's criteria. Here's the framework.

FDA-approved label criteria

Wegovy (weight management)

Wegovy CV indication (March 2024)

Zepbound (weight management)

Zepbound OSA indication (December 2024)

Ozempic / Mounjaro (T2D)

Telehealth provider criteria

Cash-pay providers typically apply criteria similar to FDA labels but may be more flexible:

Insurance prior auth (typical)

Calculating BMI

BMI = weight (kg) / [height (m)]² OR weight (lb) × 703 / [height (in)]². BMI has limitations but is the criterion in current labels and insurance criteria.

Who is NOT eligible

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.